Continuous Glucose Monitoring (CGM) and annual PAD – Peripheral Arterial Disease screenings are important test for precise treatment decisions, but unavailability of the device and lack of expertise has led to underutilization of this technology. Our unique initiatives – CGM On Call and Vascular Screening have bridged this treatment gap and enabled thousands of patients with diabetes to receive continuous blood glucose monitoring with customized medication and diet plan.
Copyright © 2022 Eris Lifesciences Limited. All Rights Reserved.